ATE264685T1 - Angesäuertes nitrit zur verwendung als antimikrobielles mittel - Google Patents

Angesäuertes nitrit zur verwendung als antimikrobielles mittel

Info

Publication number
ATE264685T1
ATE264685T1 AT95908347T AT95908347T ATE264685T1 AT E264685 T1 ATE264685 T1 AT E264685T1 AT 95908347 T AT95908347 T AT 95908347T AT 95908347 T AT95908347 T AT 95908347T AT E264685 T1 ATE264685 T1 AT E264685T1
Authority
AT
Austria
Prior art keywords
antimicrobial agent
acidified nitrite
agent
dosage form
applications
Prior art date
Application number
AT95908347T
Other languages
English (en)
Inventor
Nigel Benjamin
Hamish Dougall
Original Assignee
Univ Aberdeen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9403284A external-priority patent/GB9403284D0/en
Priority claimed from GB9404365A external-priority patent/GB9404365D0/en
Application filed by Univ Aberdeen filed Critical Univ Aberdeen
Application granted granted Critical
Publication of ATE264685T1 publication Critical patent/ATE264685T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicinal Preparation (AREA)
  • Fodder In General (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT95908347T 1994-02-21 1995-02-17 Angesäuertes nitrit zur verwendung als antimikrobielles mittel ATE264685T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9403284A GB9403284D0 (en) 1994-02-21 1994-02-21 Acidified nitrite as antimicrobial agent
GB9404365A GB9404365D0 (en) 1994-03-07 1994-03-07 Acidified nitrate as antimicrobial agent
PCT/GB1995/000338 WO1995022335A1 (en) 1994-02-21 1995-02-17 Acidified nitrite as an antimicrobial agent

Publications (1)

Publication Number Publication Date
ATE264685T1 true ATE264685T1 (de) 2004-05-15

Family

ID=26304368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95908347T ATE264685T1 (de) 1994-02-21 1995-02-17 Angesäuertes nitrit zur verwendung als antimikrobielles mittel

Country Status (17)

Country Link
EP (1) EP0746327B1 (de)
JP (1) JP3875262B2 (de)
KR (1) KR100385297B1 (de)
CN (1) CN1145491C (de)
AT (1) ATE264685T1 (de)
AU (1) AU693851B2 (de)
BR (1) BR9507099A (de)
CA (1) CA2183549C (de)
CZ (1) CZ286286B6 (de)
DE (1) DE69532921T2 (de)
DK (1) DK0746327T3 (de)
ES (1) ES2218541T3 (de)
FI (1) FI114852B (de)
NO (1) NO311494B1 (de)
PL (1) PL180769B1 (de)
PT (1) PT746327E (de)
WO (1) WO1995022335A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6709681B2 (en) 1995-02-17 2004-03-23 Aberdeen University Acidified nitrite as an antimicrobial agent
GB9804469D0 (en) * 1998-03-02 1998-04-29 Univ Aberdeen Antiviral composition
SE9700617D0 (sv) * 1997-02-21 1997-02-21 Kjell Alving New composition
AU5526399A (en) 1998-08-28 2000-03-21 University Of Bath, The Improvements in or relating to the treatment of lesions
GB9905425D0 (en) * 1999-03-09 1999-05-05 Queen Mary & Westfield College Pharmaceutical composition
GB0021317D0 (en) 2000-08-30 2000-10-18 Queen Mary & Westfield College Transdermal pharmaceutical delivery composition
GB0022084D0 (en) * 2000-09-08 2000-10-25 Univ Aberdeen Treatment of multiply antibiotic-resistant organisms
US6432077B1 (en) * 2000-12-26 2002-08-13 Sensormedics Corporation Device and method for treatment of surface infections with nitric oxide
GB0119011D0 (en) * 2001-08-03 2001-09-26 Univ Aberdeen Treatment of nail infections
DK1455888T3 (da) 2001-08-29 2009-08-24 Pharmakodex Ltd Topisk indgivelsesindretning
GB0125222D0 (en) * 2001-10-19 2001-12-12 Barts & London Nhs Trust Composition for the treatment of microbial infections
WO2005004884A2 (en) 2003-07-09 2005-01-20 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Use of nitrite salts for the treatment of cardiovascular conditions
BRPI0606829A2 (pt) * 2005-02-11 2009-07-21 Nolabs Ab dispositivo configurado, processo para fabricação de dispositivo configurado, usos de polìmero eluente de óxido nìtrico(no), método de tratamento e uso de óxido nìtrico(no)
US8557300B2 (en) 2005-05-19 2013-10-15 University Of Cincinnati Methods for treating bacterial respiratory tract infections in an individual using acidified nitrite
EP2669269B1 (de) 2005-05-27 2019-05-22 The University of North Carolina At Chapel Hill Stickoxidfreisetzende partikel für stickoxidtherapeutika und biomedizinische anwendungen
GB0604319D0 (en) * 2006-03-03 2006-04-12 Optinose As Nasal delivery
GB0607402D0 (en) * 2006-04-12 2006-05-24 Barts & London Nhs Trust Therapeutic composition and use
GB0618711D0 (en) * 2006-09-22 2006-11-01 Univ Exeter Agricultural treatment
EP2467173B8 (de) 2009-08-21 2019-06-19 Novan, Inc. Wundverbände, verfahren zu ihrer anwendung und verfahren zu ihrer herstellung
WO2011022652A1 (en) 2009-08-21 2011-02-24 Novan, Inc. Topical gels
US8591876B2 (en) 2010-12-15 2013-11-26 Novan, Inc. Methods of decreasing sebum production in the skin
WO2012118819A2 (en) 2011-02-28 2012-09-07 Novan, Inc. Nitric oxide-releasing s-nitrosothiol-modified silica particles and methods of making the same
WO2015066278A1 (en) * 2013-10-31 2015-05-07 Advanced Plasma Therapies, Inc. Methods for using nitric oxide in a plasma state to treat medical conditions and diseases
CN106604735A (zh) * 2014-06-13 2017-04-26 奥里根股份有限公司 使用电浆状态的氧化氮来治疗动物的医疗状况与疾病的兽医方法
ES3046538T3 (en) * 2014-12-05 2025-12-02 Can Tech Inc Animal feed supplement and method
DK3641777T3 (da) 2017-06-23 2026-04-13 Can Tech Inc Fremgangsmåde til forbedring af kødkvalitet
US20220370493A1 (en) 2019-06-04 2022-11-24 Thirty Holdings Limited Methods and compositions for generating nitric oxide and uses thereof
AU2020286987B2 (en) 2019-06-04 2025-09-11 Thirty Respiratory Limited Methods and compositions for generating nitric oxide and uses thereof to deliver nitric oxide via the respiratory tract
US20230172973A1 (en) 2020-04-23 2023-06-08 Thirty Respiratory Limited Methods and compositions for treating and combatting tuberculosis
WO2021214440A1 (en) 2020-04-23 2021-10-28 Thirty Respiratory Limited Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2
GB202101543D0 (en) 2021-02-04 2021-03-24 Thirty Respiratory Ltd Vaping e-liquid composition and the use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4191750A (en) * 1976-03-08 1980-03-04 Milton Hodosh Method for treating canker sores
JPS5985278A (ja) * 1982-11-05 1984-05-17 Agency Of Ind Science & Technol 食品の保存方法及び保存材
JPH0622540B2 (ja) * 1985-12-18 1994-03-30 株式会社祥光化学研究所 消臭抗菌能を有する構造物

Also Published As

Publication number Publication date
PL180769B1 (pl) 2001-04-30
NO963446L (no) 1996-10-21
PT746327E (pt) 2004-06-30
CN1144484A (zh) 1997-03-05
ES2218541T3 (es) 2004-11-16
CA2183549A1 (en) 1995-08-24
EP0746327A1 (de) 1996-12-11
JP3875262B2 (ja) 2007-01-31
AU1669995A (en) 1995-09-04
FI963232A0 (fi) 1996-08-16
DE69532921D1 (de) 2004-05-27
EP0746327B1 (de) 2004-04-21
CZ286286B6 (cs) 2000-03-15
CZ245696A3 (en) 1997-01-15
BR9507099A (pt) 1997-09-16
NO963446D0 (no) 1996-08-19
FI114852B (fi) 2005-01-14
KR100385297B1 (ko) 2003-10-10
WO1995022335A1 (en) 1995-08-24
CA2183549C (en) 2006-09-12
FI963232L (fi) 1996-09-12
DK0746327T3 (da) 2004-05-10
JPH09508921A (ja) 1997-09-09
NO311494B1 (no) 2001-12-03
DE69532921T2 (de) 2005-04-14
PL316033A1 (en) 1996-12-23
CN1145491C (zh) 2004-04-14
AU693851B2 (en) 1998-07-09

Similar Documents

Publication Publication Date Title
DE69532921D1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
GR3024836T3 (en) Fatty acid based compositions for the control of established plant infections
WO2000034265A3 (en) Quinoline-indole antimicrobial agents
MXPA02012326A (es) Peptidos quimicamente modificados, composiciones y metodos para su produccion y uso.
AU4718496A (en) Use of aerogels in agriculture
PL352318A1 (en) Fish serine proteinases, and pharmaceutical and cosmetic use of same
PT804252E (pt) Agentes queladores metalicos que contem monoaminas diamidas e tiois
HU9301550D0 (en) New hydroxamine acid and n-hydroxy-carbamide derivatives and their applications
ATE369140T1 (de) Stickstoffoxid zur behandlung therapieresistenter organismen
IL139437A0 (en) Enhancement of oxazolidinone antibacterial agents activity by using arginine derivatives
DK0964687T3 (da) Farmaceutiske sammensætninger med antimikrobiel aktivitet
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
AU3902299A (en) Methods of treating microbial infection and therapeutic formulations therefor
FI942115A0 (fi) Jodipropargyyliyhdisteiden ja 1,2-bentsisotiatsolin-3-onin synergistisiä yhdistelmiä sienten ja bakteerien kasvun estämisessä vesinesteissä
WO1999067238A3 (en) Tetrahydroquinoline-indole derivatives antimicrobial agents, their uses and compositions containing them
WO2003009859A1 (en) Immunotherapy for humans
ATE260097T1 (de) Hopfensäuren zur hemmung von staphylococcus aureus
BG105120A (en) Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
MX9603535A (es) Nitrito acido como un agente antimicrobiano.
ATE236633T1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
AU2768697A (en) Acyl urea compounds for the treatment of coccidioidomycosis in warm-blooded animals
ES8707955A1 (es) Un procedimiento para la preparacion pirazolidinonas biciclicas'
GEP20033144B (en) Hygromycin A Derivatives as Antibacterial Agents
WO2002038103A3 (en) Probiotic compositions and methods against bacterial infection in livestock animals
WO1998014567A3 (en) Methods and compositions for inhibiting bacterial growth

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0746327

Country of ref document: EP

REN Ceased due to non-payment of the annual fee